Navigation Links
Lab experiments question effectiveness of green coffee bean weight-loss supplements
Date:6/12/2013

A major ingredient in those green coffee bean dietary supplements often touted as "miracle" weight-loss products doesn't prevent weight gain in obese laboratory mice fed a high-fat diet when given at higher doses. That's the conclusion of a first-of-its-kind study published in ACS' Journal of Agricultural and Food Chemistry. It also linked the ingredient to an unhealthy build-up of fat in the liver.

Vance Matthews, Kevin Croft and their team note that coffee is rich in healthful, natural, plant-based polyphenol substances. They cite evidence from past studies that coffee drinkers have a lower risk of obesity, high blood pressure, type 2 diabetes and other disorders collectively termed the "metabolic syndrome." Chlorogenic acid (CGA), one coffee polyphenol, is the main ingredient in scores of dietary supplements promoted as weight-loss products. Much research has been done on mixtures of coffee polyphenols. Until now, however, scientists have not checked the effects of higher doses of CGA alone on obesity and other symptoms of the metabolic syndrome. Matthews' team decided to do that, using special laboratory mice that are stand-ins for humans in such tests.

They report that mice on a high-fat diet and mice on a high-fat diet plus CGA gained the same amount of weight. The CGA mice, however, were more likely to develop disorders that often lead to type 2 diabetes. They also accumulated fat inside the cells in their livers. "This study suggests that higher doses of CGA supplementation in a high-fat diet does not protect against features of the metabolic syndrome in diet-induced obese mice," they say.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Odd experiments by Americas first physiologist shed light on digestion
2. New cutting-edge cell research will lead to safer medical experiments on humans
3. Experiments may understate plant responses to climate
4. To germinate, or not to germinate, that is the question
5. Reliability of neuroscience research questioned
6. Researchers question evaluation methods for protected areas in the Amazon
7. After the Genome tackles tough questions about medicine, miracles and morality
8. Study questions the role of kinship in mass strandings of pilot whales
9. Yeast we can! New report answers questions on microbiology and beer
10. New Geology study raises questions about long-held theories of human evolution
11. Questions about biosafety? Ask a biosafety expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... ... that exhibits both viscous and elastic characteristics when deformed, which is identical to ... properties to gently absorb compressive forces and return to its natural state along ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
Breaking Biology Technology: